Ditchcarbon
  • Customers
  1. Organizations
  2. Adimmune Corporation
Public Profile
Pharmaceutical Preparation Manufacturing
TW
updated 8 days ago

Adimmune Corporation

Company website

Adimmune Corporation, a leading biopharmaceutical company based in Taiwan (TW), has been at the forefront of vaccine development since its establishment in 1965. With a strong focus on the research, production, and distribution of vaccines, Adimmune has made significant strides in enhancing public health both locally and internationally. The company is renowned for its innovative vaccine solutions, including those for influenza and other infectious diseases, which are distinguished by their high efficacy and safety profiles. Adimmune's commitment to quality and research excellence has positioned it as a key player in the global vaccine market. Over the years, Adimmune has achieved numerous milestones, solidifying its reputation as a trusted provider of vaccines. Its strategic operations extend beyond Taiwan, reaching various regions, thereby contributing to global health initiatives and responding to emerging health challenges.

DitchCarbon Score

How does Adimmune Corporation's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

21

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

28

Industry Benchmark

Adimmune Corporation's score of 21 is lower than 80% of the industry. This can give you a sense of how well the company is doing compared to its peers.

20%

Let us know if this data was useful to you

Adimmune Corporation's reported carbon emissions

In 2022, Adimmune Corporation reported total carbon emissions of approximately 17,271,000 kg CO2e, comprising 5,211,000 kg CO2e from Scope 1 and 12,060,000 kg CO2e from Scope 2 emissions. This marked an increase from 2021, when total emissions were about 15,978,000 kg CO2e, with Scope 1 emissions at 4,337,000 kg CO2e and Scope 2 emissions at 11,641,000 kg CO2e. In 2020, the company recorded total emissions of around 12,480,000 kg CO2e, with Scope 1 at 3,215,000 kg CO2e and Scope 2 at 9,265,000 kg CO2e. Despite these figures, Adimmune Corporation has not disclosed any specific reduction targets or initiatives as part of their climate commitments. The company does not currently report on Scope 3 emissions, which encompass indirect emissions in the value chain. Adimmune's emissions data is not cascaded from any parent organization, indicating that the reported figures are solely from their own operations. The company continues to monitor its emissions and is expected to enhance its climate strategies in the future.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

202020212022
Scope 1
3,215,000
0,000,000
0,000,000
Scope 2
9,265,000
00,000,000
00,000,000
Scope 3
-
-
-

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Adimmune Corporation's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Adimmune Corporation is in TW, which we do not have grid emissions data for.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Adimmune Corporation is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Sanofi

FR
•
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Bharat Biotech Ltd.

IN
•
Pharmaceutical Preparation Manufacturing
Updated 13 days ago

Baxter

US
•
Medical, precision and optical instruments, watches and clocks (33)
Updated 2 days ago

Serum Institute of India Pvt. Ltd.

IN
•
Pharmaceutical Preparation Manufacturing
Updated 13 days ago

Novartis

CH
•
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

Chengdu Institute of Biological Products Co.,Ltd.

CN
•
Pharmaceutical Preparation Manufacturing
Updated 13 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v250808.1
enquiries@ditchcarbon.com+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
Verified byUL Verified
Partnered withCDP
ProductPortalDataDocumentationIntegrationsChangelogPricing
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesMethodologyBlogFAQOrganizationsIndustriesSBTI APITrust Centre
AboutTeamCareersLicense AgreementPrivacy